These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28148634)

  • 1. From neurofilament research to multiple sclerosis clinical practice: Where do we stand?
    Bodini B; Calabresi PA
    Neurology; 2017 Feb; 88(9):816-817. PubMed ID: 28148634
    [No Abstract]   [Full Text] [Related]  

  • 2. The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level-NO.
    Arrambide G; Espejo C; Tintore M
    Mult Scler; 2015 Sep; 21(10):1240-2. PubMed ID: 26242692
    [No Abstract]   [Full Text] [Related]  

  • 3. The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES.
    Salzer J
    Mult Scler; 2015 Sep; 21(10):1239-40. PubMed ID: 25828757
    [No Abstract]   [Full Text] [Related]  

  • 4. The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level: Commentary.
    Hutchinson M
    Mult Scler; 2015 Sep; 21(10):1242-3. PubMed ID: 26242693
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurofilament in clinical practice: Is the multiple sclerosis community ready?
    Moccia M; Terracciano D; Brescia Morra V; Castaldo G
    Mult Scler; 2024 May; 30(6):643-645. PubMed ID: 38605490
    [No Abstract]   [Full Text] [Related]  

  • 6. Personalized medicine for multiple sclerosis: How to integrate neurofilament light chain levels in the decision?
    Villoslada P
    Mult Scler; 2021 Nov; 27(13):1967-1969. PubMed ID: 34612731
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurofilament in CSF-A biomarker of disease activity and long-term prognosis in multiple sclerosis.
    Soelberg Sorensen P; Sellebjerg F
    Mult Scler; 2016 Aug; 22(9):1112-3. PubMed ID: 27364323
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurofilament light in blood - What more is needed for clinical implementation in multiple sclerosis?
    Zetterberg H
    EBioMedicine; 2020 Jul; 57():102826. PubMed ID: 32574951
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma neurofilament light in progressive multiple sclerosis.
    Zetterberg H
    Acta Neurol Scand; 2020 Jan; 141(1):14-15. PubMed ID: 31618445
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis.
    Berger T; Stüve O
    Neurology; 2019 Mar; 92(10):451-452. PubMed ID: 30737335
    [No Abstract]   [Full Text] [Related]  

  • 11. CSF neurofilament light: A universal risk biomarker in multiple sclerosis?
    Khalil M; Salzer J
    Neurology; 2016 Sep; 87(11):1068-9. PubMed ID: 27521432
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum neurofilament light and prediction of multiple sclerosis in clinically isolated syndrome.
    Zetterberg H; Svenningsson A
    Neurology; 2019 Feb; 92(7):313-314. PubMed ID: 30635493
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to Hyun J.W. et al. "Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis".
    Akgün K; Ziemssen T
    Mult Scler; 2020 May; 26(6):742-743. PubMed ID: 31144585
    [No Abstract]   [Full Text] [Related]  

  • 14. Tracking therapies in MS: More evidence in favor of neurofilament.
    Yeh EA; Sormani MP
    Neurology; 2020 Mar; 94(11):465-466. PubMed ID: 32047072
    [No Abstract]   [Full Text] [Related]  

  • 15. Is CSF neurofilament light chain measurement relevant for MS?
    Matsui M
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32928895
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship Between Serum Neurofilament Light and Multiple Sclerosis Disability Progression: Clear as Mud.
    Goldschmidt C; Fox RJ
    Neurology; 2021 Nov; 97(19):887-888. PubMed ID: 34504029
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis.
    Modvig S; Degn M; Sander B; Horwitz H; Wanscher B; Sellebjerg F; Frederiksen JL
    Mult Scler; 2016 Apr; 22(5):590-8. PubMed ID: 26283696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editors' Note: Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials.
    Ganesh A; Galetta S
    Neurology; 2022 Oct; 99(14):630. PubMed ID: 36192187
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum neurofilament light as a prognostic marker for MS disability: Are we there yet?
    van Kempen ZLE; Kryscio RJ; Dalla Costa G
    Neurology; 2020 Jun; 94(23):1013-1014. PubMed ID: 32434864
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurofilament dynamics and involvement in neurological disorders.
    Gentil BJ; Tibshirani M; Durham HD
    Cell Tissue Res; 2015 Jun; 360(3):609-20. PubMed ID: 25567110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.